I would like to briefly take this opportunity to introduce you to a new state of the art Superficial Radiotherapy System, the SRT 100. The company received U.S.A. FDA 510k market clearance and European CE Certification for system use in treating skin cancer.

The SRT 100 is a totally unique product design developed through consultation with the medical community and the x-ray therapy industry. This new design provides a system that is mobile, compact in size with fully automated set-up controls, modular component electrical assembly platforms, standard wall socket plug-in operation and a wide range of motion for patient treatment flexibility.                                                   

The SRT 100 is designed to meet today’s needs of the medical practitioner for the treatment of skin cancer. The clinical needs for this special purpose system are based on changing age demographics and the increasing number of new skin cancer cases diagnosed annually. The patient is provided with a non-surgical alternative for treating primary lesions in sensitive areas. The physician is provided with a uniquely designed system for patient treatment. The practice benefits from low capital investment, improved scheduling and productivity and accepted insurance reimbursement. The payer benefits from an accepted and proven treatment method.